Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
06/2007
06/20/2007CN1982323A A preparing process of 1-(2'-deoxy-2',2'-difluoro-D-ribofuranosyl)-4-aminopyrimidin-2-on or thereof hydrochloric salt
06/20/2007CN1982301A A manufacturing process of 2',2'-difluoronucleoside and intermediate
06/14/2007WO2007067698A2 Isolation of ansamitocins
06/14/2007WO2007066737A1 Method for replication of nucleic acid and novel artificial base pair
06/14/2007WO2007065883A1 Antiviral azanucleoside derivatives
06/14/2007WO2007065829A1 Antiviral nucleosides
06/14/2007WO2007047401A3 A1 adenosine receptor agonists
06/14/2007WO2007011858A3 Use of adenine as a method for controlling immobilization of nucleic acids on gold surfaces
06/14/2007US20070135627 Hydrolysis, phosphorylation and removing protective groups; purine nucleoside phosphorylase, hydrolase
06/14/2007US20070135375 Sulfamoyl sulfonate prodrugs
06/14/2007US20070135363 For therapy of infectious diseases and proliferative disorders, such as viral infections or cancer
06/14/2007US20070134729 Novel antibacterial agents
06/14/2007CA2642657A1 Method for replicating nucleic acids and novel unnatural base pairs
06/13/2007EP1795536A1 Phosphoramidite compound and method for producing oligo-rna
06/13/2007EP1794172A1 Antiviral 4'-azido-nucleosides
06/13/2007EP1793675A2 Salts of decitabine
06/13/2007EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist
06/13/2007EP0914431B1 Truncated soluble tumor necrosis factor type-i receptors
06/13/2007CN1980946A Method for preparing A1 adenosine receptor agonists
06/12/2007US7229799 System and method for nucleic acid sequencing by polymerase synthesis
06/12/2007US7229764 System for tracing animal products
06/12/2007CA2300913C Novel compound 2-amino-3-[2-(.alpha.-mannopyranosyl)indol-3-yl]propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound
06/07/2007WO2007064291A1 Method and compounds for rna synthesis
06/07/2007WO2007038860A3 Odcase inhibitors as anti-virals and antibiotics
06/07/2007WO2007027564A3 Process for preparing gemcitabine and associated intermediates
06/07/2007US20070129325 Use of corrinoids for application in skin diseases
06/07/2007US20070128614 nucleotide triphosphate comprising an optically-detectable label attached to the nitrogenous base portion of the nucleotide via a cleavable linker
06/06/2007EP1793006A2 Nucleic acid ligands and improved methods for producing the same
06/06/2007EP1792909A1 Synthesis of polynucleotides
06/06/2007CN1974588A Method of fluorination
06/05/2007US7227019 Low cost, simple, high yield and purity synthesis of indolo[2,3-a]pyrrolo[3,4-c]carbazoles; oxidative cyclization of bisindolylmaleimide compounds
06/05/2007US7226913 Pharmaceutical compositions having A2A adenosine receptor agonist activity
06/05/2007CA2348470C Nucleosides with anti-hepatitis b virus activity
05/2007
05/31/2007WO2007061798A2 Nicotinoyl riboside compositions and methods of use
05/31/2007WO2007060886A1 Therapeutic agent for neurodegenerative disease
05/31/2007WO2007060689A2 Process for the large scale production of stavudine
05/31/2007WO2007027894A3 Antisense compounds having enhanced anti-microrna activity
05/31/2007WO2006076102A3 Fluorescent nucleoside analogs that mimic naturally occurring nucleosides
05/31/2007WO2002094185A3 Conjugates and compositions for cellular delivery
05/31/2007US20070123702 Oligonucleotdies having A-DNA form and B-DNA form conformational geometry
05/31/2007US20070122837 Mothod for the synthesis of DNA sequences
05/31/2007CA2630241A1 Methods and compositions for the treatment of gastrointestinal disorders
05/30/2007EP1790736A2 Massive parallel method for decoding DNA and RNA
05/30/2007EP1789553A2 Oligonucleotides comprising a non-phosphate backbone linkage
05/30/2007EP1789431A1 Partial and full agonists of a1 adenosine receptors
05/30/2007EP1788875A2 Novel polynucleotide synthesis labeling chemistry
05/30/2007EP1618204A4 Process for preparing dideoxyinosine using adenosine deaminase enzyme
05/30/2007EP1499576B1 Selective oxidation process with enhanced safety
05/30/2007CN1973048A Terminal-phosphate-labeled nucleotides and methods of use
05/30/2007CN1972696A Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
05/29/2007US7223744 Such as P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salts; P2Y receptor agonist with enhanced resistance to extracellular hydrolysis
05/29/2007US7223541 Using enzyme catalyst
05/29/2007CA2168080C Process for the preparation of 1-(2'-deoxy-2',2'-difluoro- d-ribopentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro- beta-d-ribo-pentopyranose
05/24/2007WO2007058278A1 Stable salt of 3'-phosphoadenosine 5'-phosphosulfate
05/24/2007WO2007009147A3 Homogemcitabines
05/24/2007WO2003084471A3 Compositions selective for adenosine diphosphate and methods of using same
05/24/2007US20070117765 Nicotinoyl riboside compositions and methods of use
05/24/2007CA2629250A1 Stable salt of 3'-phosphoadenosine 5'-phosphosulfate
05/24/2007CA2626359A1 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same
05/23/2007EP1554300B1 Phosphitylation process
05/23/2007CN1966514A Novel acyclic nucleoside phosphonate and its medical use
05/23/2007CN1317291C Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use
05/22/2007US7220854 Modified nucleotides are capable of incorporation into nucleic acids, without interfering with the formation or stabilization of the double helix, used for diagnosis and for therapy
05/22/2007US7220847 Detectable labeled nucleoside analogs and methods of use thereof
05/22/2007US7220730 Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
05/22/2007US7220423 Using a genetic vaccine that codes for conserved domains 2, 3 and 5 of a major outer membrane protein (MOMP) of a strain of Chlamydia; protection against lung infections from the strain of Chlamydia trachomatis for example
05/18/2007WO2007056213A2 Drug-eluting stents coated with p2y12 receptor antagonist compound
05/18/2007WO2007056191A2 Nucleotide sugar purification using membranes
05/18/2007WO2007055170A1 Nucleic acid base having perfluoroalkyl group and method for producing the same
05/18/2007WO2007053869A2 Novel 2,2-dithiosubstituted furanose derivatives, method for the production and use thereof
05/18/2007WO2006102970A3 Modified short interfering rna
05/18/2007CA2631129A1 Nucleobase having perfluoroalkyl group and process for producing the same
05/17/2007US20070112004 such as 2-chloro-9-(4-thio-alpha-L-xylofuranosyl)adenine for treatment of leukemia; anticancer agents
05/16/2007EP1785430A1 Rapamycin carbohydrate derivatives
05/16/2007CN1964985A 3-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereof
05/16/2007CN1964627A Methods and compositions for treating neuropathies
05/16/2007CN1316019C Anti-CD 20 embedded antibody mutant gene and its use
05/16/2007CN1315863C Beta-L-2'-deoxygenation-ramification of nucleotide, synthetic method and application of medication
05/16/2007CN1315862C Methods and compositions for treating flaviviruses and pestiviruses
05/15/2007US7217815 2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents
05/15/2007US7217814 Reacting nucleoside with cyanoethyl-N,N,N',N'-tetraisopropyl-phosphorodiamidite in presence of trifluoroacetic acid-diisopropylethylamine complex
05/15/2007US7217813 Methods for labeling nucleotides, labeled nucleotides and useful intermediates
05/15/2007US7217805 Bicyclonucleoside analogues
05/15/2007US7217335 Method of manufacturing a soft hearing aid
05/15/2007CA2156397C Rapamycin assay
05/10/2007WO2007053702A2 Synthesis of four color 3'-o-allyl modified photocleavable fluorescent nucleotides and related methods
05/10/2007US20070105812 Treating HIV-1 viral infections by administering a phospholipid choline derivative, e.g., 1-dodecanamido-2-decyloxypropyl-3-phosphocholine
05/10/2007US20070105811 Treating hepatitis B viral infections by administering a phospholipid choline derivative, e.g., 1-dodecanamido-2-decyloxypropyl-3-phosphocholine
05/10/2007US20070105154 Cell lysis composition, methods of use, apparatus, and kit
05/10/2007US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection
05/10/2007US20070105116 Metal complex type nucleic acid
05/09/2007EP1781101A2 Novel nucleoside derivatives
05/09/2007EP1364959B1 Crystal of pyrimidine nucleoside derivative
05/09/2007EP1041992A4 Hyperhydrated citicoline, process and use
05/09/2007CN1960999A Process for producing indolopyrrolocarbazole derivative
05/09/2007CN1959384A 3D gridding detection technique
05/09/2007CN1314697C Anhydrous crystalline azido cytosine hemisulfate derivative
05/08/2007US7214791 Oxidizing and fluorinating the anhydroglucose to obtain 2-deoxy-2,2-difluoro-D-ribofuranose as intermediate; can be used in large-scale production
05/08/2007US7214783 Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases
05/08/2007US7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 201